Sutro Biopharma

STRO

Börsenwert 171 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Suvretta Capital Management New York	4,63 Mio. $	-796.626 $	-97.418	-13 %
2	KCM 2 Kynam Capital Management Princeton, New Jersey	3,63 Mio. $	-288.948 $	-35.335	-6 %
3	3 Millennium Management New York	3,38 Mio. $	+3,29 Mio. $	+402.908	+573 %
4	4 Vanguard Group Malvern, Pennsylvania	2,94 Mio. $	-228.959 $	-27.999	-6 %
5	5 Velan Capital Investment Management Alpharetta, Georgia	2,18 Mio. $	+1,66 Mio. $	+203.000	+197 %
6	6 Acadian Asset Management Boston, Massachusetts	2,17 Mio. $	-75.518 $	-9.235	-3 %
7	7 Merck & Co Rahway, New Jersey	1,94 Mio. $	–	–	–
8	8 Vestal Point Capital New York	1,86 Mio. $	–	–	–
9	9 Tang Capital Management San Diego, California	1,83 Mio. $	+1,93 Mio. $	+236.159	+1.181 %
10	10 Eversept Partners New York	1,64 Mio. $	–	–	–
11	11 Samsara BioCapital Palo Alto, California	1,57 Mio. $	–	–	–
12	12 BlackRock New York	1,5 Mio. $	-3,35 Mio. $	-409.777	-66 %
13	13 Adage Capital Partners Boston, Massachusetts	1,43 Mio. $	–	–	–
14	14 UBS Group Zurich, Switzerland	1,16 Mio. $	+1,26 Mio. $	+154.331	+2.042 %
15	15 AQR Capital Management Greenwich, Connecticut	722.977 $	-252.027 $	-30.820	-23 %
16	16 Renaissance Technologies New York	651.931 $	+36.144 $	+4.420	+5 %
17	17 Geode Capital Management Boston, Massachusetts	583.406 $	-876.903 $	-107.235	-57 %
18	18 Affinity Asset Advisors New York	537.368 $	–	–	–
19	19 Jane Street New York	491.770 $	+563.300 $	+68.885	Neu
20	20 Dimensional Fund Advisors Austin, Texas	448.832 $	-154.561 $	-18.901	-23 %
21	21 Cantor Fitzgerald New York	356.950 $	+408.870 $	+50.000	Neu
22	22 DAFNA Capital Management Los Angeles, California	312.031 $	–	–	–
23	23 Goldman Sachs New York	289.664 $	-1,07 Mio. $	-130.637	-76 %
24	24 LPL Financial San Diego, California	264.677 $	-15.684 $	-1.918	-5 %
25	25 Fisher Asset Management Camas, Washington	251.970 $	–	–	–

Sutro Biopharma STRO Börsenwert 171 Mio. $

Sutro Biopharma

STRO

Börsenwert 171 Mio. $